Upload
bio-link
View
1.171
Download
6
Embed Size (px)
DESCRIPTION
Welcoming message given by Sonia Wallman, of the Organizing Committee, and Lance Hartford, the Executive Director of the Massachusetts Biotechnology Education Foundation.
Citation preview
Community College Program
Welcome
Annual Community College Program Day
Organizing Committee
• Sonia Wallman – Executive Director NBC2• Elaine Johnson – Bio-Link Director• Russ Read – National Center, NC BioNetwork• Lance Hartford – MassBioEd Foundation• Margaret Bryans – PI NBC2, Montgomery County
Community College• Lisa Seidman – Madison Area Technical College • Tim Dubuque - NBC2
Massachusetts BioPharma Employment Continues Growth
The industry weathered the 2009 downturn without an employment drop.
53%Growthsince 2002 Source: U.S. Census, County Business Patterns and MassBio formula and analysis.
*2011 figure is a preliminary estimate based on review of Massachusetts ES-202 data for 2010-2011.
Biotechnology R&D Employment
According to the Bureau of Labor Statistics’ Quarterly Census of Employment & Wage (QCEW) data, Massachusetts leads the nation in biotechnology research & development employment.
Source: U.S. Bureau of Labor Statistics, Quarterly Census of Employment and Wages (QCEW)
2007 2010CA 19,134 21,616CT 2,452 1,582MA 24,565 26,807MD 10,154 9,469MI 4,670 2,759MO 4,262 3,874NJ 8,567 9,224NY 2,679 3,553NC 7,042 6,275PA 15,902 12,776WA 2,499 3,730
Total Trials PC I II III PA% of US 9.41% 11.00% 11.99% 8.26% 8.46% 3.89%% of Global 4.91% 5.88% 6.43% 4.56% 3.52% 1.44%
Drug Development Pipeline, August 2011
Pre-Clinical 316
Phase I 216
Phase II 275
Phase III 76
Pending Approval 14
Candidate medicines of Massachusetts-headquartered* companies, by clinical trials stage
Massachusetts-headquartered companies’ share of U.S. and Global drug development pipeline
* There are many drugs in development in Massachusetts by companies with headquarters located outside of Massachusetts. These candidate drugs are not included in any Massachusetts pipeline estimates found in this report.
Massachusetts- headquartered companies* account for about 10% of the U.S. drug development pipeline and 5% of the global pipeline.
Source: MedTrack Online, Life Sciences Analytics, Inc.
Of the 897 drugs in the Massachusetts pipeline, 42.7% are cancer drugs.
Drugs intended for the Central Nervous System (CNS) therapeutic area are next at 10.1% of the pipeline.
Massachusetts Pipeline by Therapeutic Area
Total Trials CompaniesCancer 383 59Central Nervous System 91 35Infectious 84 30Autoimmune and Inflammation 61 33Metabolic/Endocrinology 47 23Ophthalmology and Optometry 32 13Respiratory and Pulmonary System 32 20Blood and Lymphatic System 30 16Cardiovascular & Circulatory 25 36Musculo-Skeletal-Disorders 24 11Digestive 19 15Dermotology 18 15Kidney & Genito-Urinary 13 10Genetic Diseases & Dysmorphic Syndromes 11 6Substance Abuse 10 5Women's Health 9 6Miscellaneous 8 7
Source: MedTrack Online, Life Sciences Analytics, Inc.
Source Data: 2011 PricewaterhouseCoopers, National Venture Capital Association, MoneyTreeTM Report, Historical Trend Data, and MassBio analysis.
Venture Capital Investment
$1.071 billion invested in MA biotechs in 2011 is an historic high.
$8.054billion since 2002
Source: 2011 PricewaterhouseCoopers, National Venture Capital Association, MoneyTreeTM Report, Historical Trend Data, MassBio
analysis.
MA Share of the Biotech VC Dollar
MA biotechs received 22.6% of all VC biotech financing, just below the 2010 all-time high.
Leading BioPharma Employers (MA), 2011
1. Genzyme (Sanofi) 4,3562. Pfizer 2,6003. Biogen Idec 2,3004. Novartis 2,1005. Thermo Fisher Scientific 1,7006. Shire 1,5007. Vertex 1,3108. EMD Millipore 1,2379. Parexel International 1,20010. Millenium: Takeda Oncology 1,05011. Charles River Laboratories 97012. AstraZeneca 90013. EMD Serono 85014. Hologic 80015. Abbott Laboratories 75016. Sunovion Pharmaceuticals (DSP) 69017. Nova Biomedical 63118. Cubist 62619. Lantheus 55019. Merck 33020. Bristol-Myers Squibb 320
Sources: MassBio, membership reports, survey, Boston Business Journal Book of Lists, 2011.
MA has benefited from the pharma industry’s embrace of biotechnology.
Mass Biomanufacturing
Of the top 11 biopharma manufacturing states, Massachusetts was one of just four which added manufacturing jobs in the last decade
$4,615,364,513 in payroll (2010)
$95,628 in average salary (2010)
BioPharma Industry Impact in MA
The estimated average salary in the biopharma industry is 77% higher than the estimated state average salary of $53,834.
Massachusetts Exports, 2010All Commodities 26,256,370,201Optic, Photo Etc, Medic Or Surgical Instrments Etc 5,324,511,940 20.20%Industrial Machinery, Including Computers 4,601,715,086Electric Machinery Etc; Sound Equip; Tv Equip; Pts 4,518,662,880Pharmaceutical Products 2,136,306,456 8.10%
Source: MassExport Center
Source: U.S. Census, County Business Patterns, MassBio estimate using 2009 base data .
430+Biotech
Companies
122Colleges &Universities
Top 5NIH fundedResearchHospitals
1stin
Venture Capital & SBIR funds per worker
1stin
Education Level of
workforce
500+BiopharmaCompanies
122Colleges &Universities
Top 5NIH funded
Research
Hospitals
1stin
Venture Capital & federal research
funds per worker
1stin
Education Level of
Workforce (US)
Why Massachusetts?
SupportiveLocal, State Government
Life Sciences InitiativeBiotech Caucus
The $1 Billion Massachusetts Life Sciences Initiative
• 10 years• $1 billionInvestment$5
00 m
illio
n C
apita
l
Fund
$250 million
Tax Incentive Program
$250m Investment Fund (subject to appropriation)
Over time, the industry demonstrated its value, commitment to the region, and promise for the future . . . and state government responded.
U.S. Department of Labor to receive the Trade Adjustment Assistance Community College and Career Training Grant. $20M
The Metro Boston Skilled Careers in Life Sciences (SCILS) initiative $5M – Life Sciences Center & Quincy College
Mass Life Science Center Internship Program - since the program first launched in 2009, the Center has placed 794 interns at more than 250 companies throughout Massachusetts!
MassBioEd Foundation’s industry endorsement of eight community college programs
Education and Workforce Development Initiatives
Northeast Biomanufacturers and Community Colleges with Biomanufacturing